Previous 10 | Next 10 |
Sesen Bio (NASDAQ: SESN) had a tumultuous Friday. On a generally fine day for stocks, the company's shares fell by almost 10%. A clutch of law firms are coming for it, and investors are stepping away. On Friday, several fresh lawsuits against Sesen Bio were announced. As they we...
BOSTON, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Block & Leviton announces that a class action lawsuit has been filed against Sesen Bio Inc. (NASDAQ: SESN) and certain of its officers for securities law violations. Investors who purchased shares between December 21, 2020 and August 17, 2021 an...
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sesen Bio, Inc. (“Sesen” or the “Company”) (NASDAQ: SESN) on behalf of Sesen stockholders. Our investigation concerns whether S...
Gainers: PharmaCyte Biotech (NASDAQ:PMCB) +118%. Virpax Pharmaceuticals (NASDAQ:VRPX) +59%. SGOCO Group (NASDAQ:SGOC) +53%. AzurRx BioPharma (NASDAQ:AZRX) +30%. NRx Pharmaceuticals (NASDAQ:NRXP) +26%. Standard Lithium (NYSE:SLI) +21%. ESSA Pharma (NASDAQ:EPIX) +15%. Agrify (NASDAQ:AGFY) +17%....
One day has made a huge difference for the stock of Sesen Bio (NASDAQ: SESN) . On Tuesday, the shares blasted almost 24% higher (albeit from a low base of $1.22 per share), a day after cratering by 42%. What in the world is going on with this volatile stock? Monday's steep dive ...
These 3 Biotech Penny Stocks Could Be Worth Looking Into Over the past year and a half, biotech penny stocks have remained some of the hottest small caps for investors of all types. And, there are a few reasons why this is the case. First and foremost, biotech penny stocks present a...
Federman & Sherwood announces an investigation into Sesen Bio (NASDAQ: SESN). The complaint will allege violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or fal...
Gainers: Virpax Pharmaceuticals (NASDAQ:VRPX) +220%. Alfi (NASDAQ:ALF) +27%. Aerpio Pharmaceuticals (NASDAQ:ARPO) +26%. Sesen Bio (NASDAQ:SESN) +23%. monday.com (NASDAQ:MNDY) +20%. Eco Wave Power Global AB (publ) (NASDAQ:WAVE) +17%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Connec...
Gainers: Virpax Pharmaceuticals (NASDAQ:VRPX) +96%, Sesen Bio (NASDAQ:SESN) +28%, Terns Pharmaceuticals (NASDAQ:TERN) +16%, 23andMe (NASDAQ:ME) +16%, NanoVibronix (NASDAQ:NAOV) +9%. Losers: Qualigen Therapeutics (NASDAQ:QLGN) -16%, Sema4 ...
It's tough when any onetime highflier falls precipitously from its height. Such was the case with ambitious biotech Sesen Bio (NASDAQ: SESN) , which saw its share price decline by a queasy 42% on Monday following continued fallout from a very discouraging communication from the FDA....
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...